GLP1R and prediabetes syndrome: It is also possible that the larger improvement in individuals with prediabetes or diabetes is the result of the increasing use of glucagon-like peptide-1 receptor agonists (GLP-1RA) [39], which are more frequently prescribed in these individuals.